# OGG1 and MUTYH DNA Glycosylases, the Dynamic Duo Against 8-Oxoguanine DNA Lesion: Structure, Regulation, and Novel Emerging Roles

**Authors:** Ana P. Gómez-Ramírez, Melody Malek, Estela G. García-González, Sergio E. Campos, Luis G. Brieba, Sheila S. David, Carlos H. Trasviña-Arenas

PMC · DOI: 10.3390/biom16020257 · Biomolecules · 2026-02-05

## TL;DR

This paper reviews the roles of OGG1 and MUTYH enzymes in repairing DNA damage caused by 8-oxoguanine, highlighting their structure, regulation, and impact on diseases.

## Contribution

The paper provides a comprehensive review of the structure, regulation, and emerging roles of OGG1 and MUTYH DNA glycosylases.

## Key findings

- OGG1 and MUTYH are essential for repairing 8-oxoguanine lesions in DNA.
- Dysfunction in these enzymes is linked to neurodegenerative diseases, metabolic syndromes, and cancer.
- Regulation of these enzymes is critical to prevent genomic instability and cell death.

## Abstract

OGG1 and MUTYH are base excision repair (BER) DNA glycosylases (DGs) from the Helix–hairpin–Helix superfamily responsible for initiating and coordinating the repair of 8-oxo-7,8-dihydroguanine (OG), and its replication-derived mispair with adenine (OG:A), respectively. The DNA repair activities of these DGs are pivotal to safeguarding nuclear and mitochondrial genomes. Indeed, DG functional impairment is associated with numerous pathologies, including neurodegenerative diseases, metabolic syndromes, and cancer. The timely and precise localization and processing of oxidized nucleobases carried out by these DGs are modulated by a complex regulatory network at both transcriptional and posttranslational levels, as well as intricate protein–protein interaction networks. In the absence of regulation, inappropriate and imbalanced DG activity may trigger telomeric instability, changes in transcriptional profiles and cell death. This review focuses on summarizing key features of OGG1 and MUTYH function, with a special emphasis on structure, regulation, and novel emerging roles.

## Linked entities

- **Genes:** OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968], MUTYH (mutY DNA glycosylase) [NCBI Gene 4595]
- **Chemicals:** 8-oxo-7,8-dihydroguanine (PubChem CID 135420630), adenine (PubChem CID 190)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** FEN1 (flap structure-specific endonuclease 1) [NCBI Gene 2237] {aka FEN-1, MF1, RAD2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, RAD9A (RAD9 checkpoint clamp component A) [NCBI Gene 5883] {aka RAD9}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, TFAP4 (transcription factor AP-4) [NCBI Gene 7023] {aka AP-4, bHLHc41}, Ogg1 (8-oxoguanine DNA-glycosylase 1) [NCBI Gene 18294] {aka Mmh}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, RAD1 (RAD1 checkpoint DNA exonuclease) [NCBI Gene 5810] {aka HRAD1, REC1}, XPC (XPC complex subunit, DNA damage recognition and repair factor) [NCBI Gene 7508] {aka RAD4, XP3, XPCC, p125}, LIG3 (DNA ligase 3) [NCBI Gene 3980] {aka LIG2, LIG3alpha, MTDPS20}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, PIP (prolactin induced protein) [NCBI Gene 5304] {aka BRST-2, GCDFP-15, GCDFP15, GPIP4}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, RAD52 (RAD52 DNA repair protein) [NCBI Gene 5893], MUL1 (mitochondrial E3 ubiquitin protein ligase 1) [NCBI Gene 79594] {aka C1orf166, GIDE, MAPL, MULAN, RNF218}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, SIRT6 (sirtuin 6) [NCBI Gene 51548] {aka SIR2L6, hSIRT6}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, NEDD4L (NEDD4 like E3 ubiquitin protein ligase) [NCBI Gene 23327] {aka NEDD4-2, NEDD4.2, PVNH7, RSP5, hNEDD4-2}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, ARC (activity regulated cytoskeleton associated protein) [NCBI Gene 23237] {aka Arg3.1, hArc}, HCFC1 (host cell factor C1) [NCBI Gene 3054] {aka CFF, HCF, HCF-1, HCF1, HFC1, MAHCX}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NRF1 (nuclear respiratory factor 1) [NCBI Gene 4899] {aka ALPHA-PAL}, NEIL3 (nei like DNA glycosylase 3) [NCBI Gene 55247] {aka FGP2, FPG2, NEI3, ZGRF3, hFPG2, hNEI3}, HDAC1 (histone deacetylase 1) [NCBI Gene 3065] {aka GON-10, HD1, KDAC1, RPD3, RPD3L1}, Msh2 (mutS homolog 2) [NCBI Gene 17685], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Msh6 (mutS homolog 6) [NCBI Gene 17688] {aka GTBP, Gtmbp}, SIRT2 (sirtuin 2) [NCBI Gene 22933] {aka SIR2, SIR2L, SIR2L2}, Mutyh (mutY DNA glycosylase) [NCBI Gene 70603] {aka 5730495A01Rik, Mutyha, Mutyhalpha, Mutyhb, Mutyhbeta, Mutyhc}, SP1 (Sp1 transcription factor) [NCBI Gene 6667], SLC25A15 (solute carrier family 25 member 15) [NCBI Gene 10166] {aka D13S327, HHH, LNC-HC, ORC1, ORNT1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515] {aka RCC, SCAR26}, NEIL1 (nei like DNA glycosylase 1) [NCBI Gene 79661] {aka FPG1, NEI1, hFPG1}, HUS1 (HUS1 checkpoint clamp component) [NCBI Gene 3364] {aka hHUS1}, ST13 (ST13 Hsp70 interacting protein) [NCBI Gene 6767] {aka AAG2, FAM10A1, FAM10A4, HIP, HOP, HSPABP}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) [NCBI Gene 25] {aka ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, SYNM (synemin) [NCBI Gene 23336] {aka DMN, SYN}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, NUDT1 (nudix hydrolase 1) [NCBI Gene 4521] {aka MTH1}, NFYA (nuclear transcription factor Y subunit alpha) [NCBI Gene 4800] {aka CBF-A, CBF-B, HAP2, NF-YA}, MUTYH (mutY DNA glycosylase) [NCBI Gene 4595] {aka MYH}, DGCR (DiGeorge syndrome chromosome region) [NCBI Gene 1714] {aka CATCH22, DGS, VCF}, LIG1 (DNA ligase 1) [NCBI Gene 3978] {aka IMD96, LIGI, hLig1}, ERCC6 (ERCC excision repair 6, chromatin remodeling factor) [NCBI Gene 2074] {aka ARMD5, CKN2, COFS, COFS1, CSB, CSB-PGBD3}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit) [NCBI Gene 1161] {aka CKN1, CSA, UVSS2}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, NTHL1 (nth like DNA glycosylase 1) [NCBI Gene 4913] {aka FAP3, NTH1, OCTS3, hNTH1}
- **Diseases:** Parkinson's (MESH:D010300), polyposis (MESH:D044483), neurodegeneration (MESH:D019636), injury to (MESH:D014947), airway inflammation (MESH:D007249), metabolic syndromes (MESH:D024821), impairment (MESH:D060825), AD (MESH:D000544), diabetes (MESH:D003920), Tumor (MESH:D009369), AKI (MESH:D058186), oncogenes (MESH:D000074723), carcinogenesis (MESH:D063646), neurological diseases (MESH:D020271), ischemia (MESH:D007511), hyperthermia (MESH:D005334), ARCs (MESH:C563333), carcinogenic (MESH:D011230), CRC (MESH:D015179), leukemia (MESH:D007938), MAP (MESH:D011125), cytotoxic (MESH:D064420), proinflammatory genes (MESH:C537680), ovarian, bladder, breast, and others (MESH:D010051), breast cancer (MESH:D001943), prostate (MESH:D011472), eye disease (MESH:D005128)
- **Chemicals:** Zn (MESH:D015032), FapyG (MESH:C071023), menadione (MESH:D024483), Guanine (MESH:D006147), C (MESH:D002244), thymine (MESH:D013941), 17 beta-estradiol (MESH:D004958), cytosine (MESH:D003596), Schiff base (MESH:D012545), hydroxyl (MESH:D017665), DTT (MESH:D004229), methyl parathion (MESH:D008743), adenine (MESH:D000225), DDB (MESH:C010098), H2O2 (MESH:D006861), Cisplatin (MESH:D002945), organophosphate (MESH:D010755), 5'-2-deoxyribose-5-phosphate (-), 2-hydroxyad enine (MESH:C008183), 8-Oxoguanine (MESH:C024829), serine (MESH:D012694), KBrO3 (MESH:C019536), cysteine (MESH:D003545), sterol (MESH:D013261), calcium (MESH:D002118), Lys (MESH:D008239), G:A (MESH:D005708), NAD (MESH:D009243), A (MESH:D001151), Cadmium (MESH:D002104)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** Lys521) to Arg, Ser24, Ser511, Ser505, Ser508, G to T mutations in codon 12, N146S, S538D, S326C, Ser538
- **Cell lines:** HEK293FT — Homo sapiens (Human), Transformed cell line (CVCL_6911), U2O2 — Mus musculus (Mouse), Hybridoma (CVCL_C0ZA), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), HBE — Homo sapiens (Human), Transformed cell line (CVCL_0287), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), H2009 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1514), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938805/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938805/full.md

## References

261 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938805/full.md

---
Source: https://tomesphere.com/paper/PMC12938805